Home › Cancer (all types) › NCT07224204
Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers
Life at 100.4: An Immersive Social Virtual Reality Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers
Who can join
Ages 13 to 39 · All sexes
Full eligibility criteria
Inclusion Criteria: * Newly diagnosed with a malignancy or bone marrow failure condition * Planned to receive chemotherapy and receive a central line Exclusion Criteria: * Medical contraindication to virtual reality including head wounds and history of seizure with flashing lights * No plan to receive chemotherapy
About the study
The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.
What is being tested
- Life at 100.4 (behavioral)
Sponsor: Yale University · Participants: 45 · Started: Feb 11, 2026
Contact the study team
- Asher Marks, MD · Phone: 203-785-4640
- Vidya Puthepura, MD · Phone: 203-785-4640
Official record on ClinicalTrials.gov — NCT07224204
Locations in the U.S.
| Connecticut | Pediatric Hematology/Oncology Clinic in Smilow Cancer Hospital, New Haven |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.